Will we launch in Q1?

[anonymous]

I know management said it maybe longer, any chance we can launch in Q1?

 

[anonymous]

I know management said it maybe longer, any chance we can launch in Q1?

June/July

 

[anonymous]

Mid April

 

[anonymous]

Mid April

Of 2022

 

[anonymous]

Of 2022

let’s just focus on increasing market share with these two products we have.

 

[anonymous]

let’s just focus on increasing market share with these two products we have.

Not sure if all the focus in the world can help when it’s not covered and too expensive.

 

[anonymous]

Not sure if all the focus in the world can help when it’s not covered and too expensive.

if you can’t sell then you can’t sell

 

[anonymous]

if you can’t sell then you can’t sell

It doesn’t matter how great a product is, if when you go to purchase that product at the store it’s too expensive. We are well beyond the you can’t sell argument. Corporate Accounts had opportunities over the years to sign contracts with payers but we let our ego get in the way. So just shut up already.

 

[anonymous]

Not sure if all the focus in the world can help when it’s not covered and too expensive.

1 month supply (100mg or equivalent)

Trokendi - $750
Qudexy/topiramate ER - $475
Topiramate - $10

Ajovy - $600
Aimovig - $600
Emgality - $560

 

[anonymous]

1 month supply (100mg or equivalent)

Trokendi - $750
Qudexy/topiramate ER - $475
Topiramate - $10

Ajovy - $600
Aimovig - $600
Emgality - $560

That’s 9000 a year for ONE script. Meanwhile reps are hardly bonusing. This place is a joke. Leaving first chance I get

 

[anonymous]

if you can’t sell then you can’t sell

The moment the rep gets the doctor to put pen to pad that doctor is sold. What happens after the script is written is out of the reps control. That’s where Supernus should be held responsible not the rep.

 

[anonymous]

That’s 9000 a year for ONE script. Meanwhile reps are hardly bonusing. This place is a joke. Leaving first chance I get

This is honestly a PSA. Since you want to leave and will have to interview in order to do so, please make an effort to properly understand industry pricing and payer dynamics. If you want to move on to make more money, explaining away low growth being due to the price of your product will not get you the job.

 

[anonymous]

This is honestly a PSA. Since you want to leave and will have to interview in order to do so, please make an effort to properly understand industry pricing and payer dynamics. If you want to move on to make more money, explaining away low growth being due to the price of your product will not get you the job.

Not the OP but I think they were trying to point out the irony in high priced medications and low bonus payout. Which is exactly what we see at supernus.

 

[anonymous]

That’s 9000 a year for ONE script. Meanwhile reps are hardly bonusing. This place is a joke. Leaving first chance I get

Leave now? When the Q1 bonus is probably the best our company has ever seen? Big mistake. Huge!

(cough)

 

[anonymous]

Leave now? When the Q1 bonus is probably the best our company has ever seen? Big mistake. Huge!

(cough)

 

[anonymous]

Can we at least get some update on 812? It’s been 2 months without one word on approval date

 

[anonymous]

The fact that we are coming up on 3 months and still no word tells me that Q2 launch is very ambitious.

 

[anonymous]

The fact that we are coming up on 3 months and still no word tells me that Q2 launch is very ambitious.

So you’re saying that 2 months and 3 days is “coming up on 3 months?

 

[anonymous]

So you’re saying that 2 months and 3 days is “coming up on 3 months?

so you’re telling me that we will launch April first? You’re lying to your self.

 

[anonymous]

So you’re saying that 2 months and 3 days is “coming up on 3 months?

I’m not even arguing for launch here I’m asking for any news whatsoever. I think 2 months and 3 days is excessive with no word